Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen.
Bender NG, Khare P, Martinez J, Tweedell RE, Nyasembe VO, López-Gutiérrez B, Tripathi A, Miller D, Hamerly T, Vela EM, Davis RR, Howard RF, Nsango S, Cobb RR, Harbers M, Dinglasan RR.
Bender NG, et al. Among authors: vela em.
NPJ Vaccines. 2021 Apr 6;6(1):49. doi: 10.1038/s41541-021-00309-4.
NPJ Vaccines. 2021.
PMID: 33824336
Free PMC article.